Eric Richardson1, Kathleen A Ryan2, Robert M Lawrence2, Christopher A Harle1, Shivani M Desai1, Melvin D Livingston3, Amit Rawal4, Stephanie A S Staras1,5. 1. Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL, USA. 2. Department of Pediatrics, College of Medicine, University of Florida, Gainesville, FL, USA. 3. Rollins School of Public Health, Emory University, Atlanta, GA, USA. 4. Avnee Foundation, Gainesville, FL, USA. 5. The Institute for Child Health Policy, University of Florida, Gainesville, FL, USA.
Abstract
Objective: At a large public university, we aimed to evaluate an intervention designed to increase serogroup B meningococcal (MenB) vaccine uptake and awareness. Methods: Using a pretest-posttest design with a double posttest, we evaluated an intervention conducted by a local foundation and the Florida Department of Health that distributed MenB vaccine on campus and conducted an educational campaign. Prior to intervention activities, we recruited students to complete a survey about their MenB knowledge and attitudes. For survey participants who provided contact information, we sent two follow-up surveys and assessed MenB vaccine records. We used chi-square tests, adjusted for nonindependence, to compare preintervention to postintervention (three-month and one-year) vaccination and attitudes. Results: Among the 686 students with accessible vaccine records, MenB vaccine initiation increased 9% (from 24% to 33%) and completion increased 8% (from 13% to 21%) from before the intervention to one year after the intervention. When restricting to students who completed the relevant follow-up surveys, the percentage of students who heard of the MenB vaccine increased by 15% (p > .001) from before the intervention to three months after (n = 188 students) and maintained a 10% increase (p > .001) one year after the intervention (n = 261 students). Among students that heard of the MenB vaccine, the percentage of students who thought they needed the MenB vaccine even though they received the MenACWY increased 14% (p = .03) by the three-month postintervention survey and up to 18% by the one-year follow-up (p = .002).Conclusions: A university-wide, on-campus vaccination and educational campaign increased college students' MenB vaccine initiation, completion, and knowledge.Clinicaltrials.gov ID: NCT02975596.
Objective: At a large public university, we aimed to evaluate an intervention designed to increase serogroup B meningococcal (MenB) vaccine uptake and awareness. Methods: Using a pretest-posttest design with a double posttest, we evaluated an intervention conducted by a local foundation and the Florida Department of Health that distributed MenB vaccine on campus and conducted an educational campaign. Prior to intervention activities, we recruited students to complete a survey about their MenB knowledge and attitudes. For survey participants who provided contact information, we sent two follow-up surveys and assessed MenB vaccine records. We used chi-square tests, adjusted for nonindependence, to compare preintervention to postintervention (three-month and one-year) vaccination and attitudes. Results: Among the 686 students with accessible vaccine records, MenB vaccine initiation increased 9% (from 24% to 33%) and completion increased 8% (from 13% to 21%) from before the intervention to one year after the intervention. When restricting to students who completed the relevant follow-up surveys, the percentage of students who heard of the MenB vaccine increased by 15% (p > .001) from before the intervention to three months after (n = 188 students) and maintained a 10% increase (p > .001) one year after the intervention (n = 261 students). Among students that heard of the MenB vaccine, the percentage of students who thought they needed the MenB vaccine even though they received the MenACWY increased 14% (p = .03) by the three-month postintervention survey and up to 18% by the one-year follow-up (p = .002).Conclusions: A university-wide, on-campus vaccination and educational campaign increased college students' MenB vaccine initiation, completion, and knowledge.Clinicaltrials.gov ID: NCT02975596.
Authors: Elizabeth Packnett; Debra E Irwin; Patricia Novy; Philip S Watson; Jane Whelan; Laura Moore-Schiltz; Matthew Lucci; Cosmina Hogea Journal: Vaccine Date: 2019-08-20 Impact factor: 3.641
Authors: D M MacDougall; J M Langley; L Li; L Ye; D MacKinnon-Cameron; K A Top; S A McNeil; B A Halperin; A Swain; J A Bettinger; E Dubé; G De Serres; S A Halperin Journal: Vaccine Date: 2017-03-24 Impact factor: 3.641
Authors: Emily A Fisher; Tasha Poissant; Patrick Luedtke; Richard Leman; Collette Young; Paul Cieslak Journal: J Adolesc Health Date: 2018-08 Impact factor: 5.012
Authors: Sara E Oliver; Monica E Patton; Mary Hoban; Victor Leino; Sarah A Mbaeyi; Susan Hariri; Jessica R MacNeil Journal: J Am Coll Health Date: 2019-11-11
Authors: Heidi M Soeters; Lucy A McNamara; Amy E Blain; Melissa Whaley; Jessica R MacNeil; Susan Hariri; Sarah A Mbaeyi Journal: Emerg Infect Dis Date: 2019-03 Impact factor: 6.883